Moderna Inc. stock falls Thursday, underperforms market

Shares of Moderna Inc.
MRNA,
-5.71%
slid 5.71% to $210.17 Thursday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index
COMP,
-2.51%
falling 2.51% to 14,806.81 and Dow Jones Industrial Average
DJIA,
-0.49%
falling 0.49% to 36,113.62. Moderna Inc. closed $287.32 short of its 52-week high ($497.49), which the company achieved on August 10th.

The stock underperformed when compared to some of its competitors Thursday, as AbbVie Inc.
ABBV,
-1.74%
fell 1.74% to $133.52, Amgen Inc.
AMGN,
-0.39%
fell 0.39% to $230.85, and AstraZeneca PLC ADR
AZN,
-0.51%
fell 0.51% to $58.10. Trading volume (7.3 M) remained 5.3 million below its 50-day average volume of 12.6 M.